Curtin Health Innovation Research Institute (CHIRI) bio-nanotechnology researcher Dr Hani Al-Salami has two international research projects ‘on the horizon’, with the European Union (EU) providing funds totalling $5.5 million (€3.332 million) over five years, through the EU-Horizon 2020 Research and Innovation Program.
The grants are designed to encourages world-class science by removing barriers to knowledge, research and innovation thorough research partnerships, and focusing on inter-disciplinary collaboration of world-leading scientists and Hani is the lead Australian scientific advisor and co-investigator on both projects.
One project will focus on developing nanosensors that can rapidly analyse saliva to understand metabolic responses to drugs and treatments. The second project is designed to develop drug delivery systems including through patch technologies and electronic implants. Both projects require multidisciplinary teams including in medicine, physics and engineering.
The EU’s funding for these particular projects is through a European Research Area Chairs and RISE grants, which supports research programs, infrastructure and building capacity to integrate its scientific resources and support cooperation in the fields of medical, environmental, and socioeconomic research.
“My and CHIRI’s involvement is part of several long-standing collaborations in EU-funded projects which started with my EU MEDLEM project and now covers more than 12 EU labs, industry sponsors, and world-class researchers” Hani said. “These collaborations provide opportunities for CHIRI to contribute research expertise to projects with great potential to make scientific advances that would benefit disease patients in Australia, Europe and around the world.”
The two collaborative projects funded involve chief investigators from multiple European academic and industrial organisations including AYUS GmbH in Germany, WEST Aquila in Italy, Naturality Research and Development in Spain and Materials Research Centre in the Ukraine.